Santhera Pharmaceuticals Holding AG (SANN.SW) SIX

14.34

+0.12(+0.84%)

Updated at September 09 02:00PM

Currency In CHF

Valuation

Market Cap157.2M
Enterprise Value156.9M
P/E Ratio-3.89
PEG Ratio0.02
Price/Sales Ratio4.75
Price/Book Ratio5.9
Enterprise/Revenue4.74
Enterprise/EBITDA-11.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-1.07
Operating Margin-0.85

Management Effectiveness

Return On Assets-0.28
Return On Equity-1.11

Income Statement

Revenue39.12M
Revenue/Share3.43
Gross Profit22.96M
EBITDA-15.89M
Net Income-41.97M
Diluted EPS-3.69

Balance Sheet

Total Cash40.92M
Total Cash/Share3.59
Total Debt40.62M
Total Debt/Equity1.47
Current Ratio1.64
Book Value Per Share2.43

Price History

52-Week Change55.87
52-Week High17.76
52-Week Low7.21
Moving Average 50 Days13.56
Moving Average 200 Days13.5

Statistics

Average Volume31,445
Shares Outstanding12.95M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJuly 03, 2023